Estimated risk of transfusion-transmitted HIV infection in Sao Paulo, Brazil

Transfusion ◽  
1999 ◽  
Vol 39 (10) ◽  
pp. 1152-1152 ◽  
Author(s):  
Ester C. Sabino ◽  
Nanci Salles ◽  
Amadeo Saez-Alquezar ◽  
Gabriela Ribeiro-dos-Santos ◽  
Dalton F. Chamone ◽  
...  
2001 ◽  
Vol 15 (7) ◽  
pp. 391-397 ◽  
Author(s):  
Carla Gianna Luppi ◽  
José Eluf-Neto ◽  
Ester Sabino ◽  
Valeria Buccheri ◽  
Claudia Barreto ◽  
...  

2019 ◽  
Author(s):  
Mariza Tancredi ◽  
Valdir Pinto ◽  
Ângela Tayra ◽  
Marcia Polon ◽  
Carmen Silvia Domingues

Author(s):  
Marizete M. C. Ferreira ◽  
Lucilaine Ferrazoli ◽  
Moises Palaci ◽  
Paulo S. Salles ◽  
Lucas A. Medeiros ◽  
...  

1999 ◽  
Vol 10 (2) ◽  
pp. 98-104
Author(s):  
D M T Zanetta ◽  
L Strazza ◽  
R S Azevedo ◽  
H B Carvalho ◽  
E Massad ◽  
...  

Author(s):  
Maria Cássia J. MENDES-CORRÊA ◽  
Antonio Alci BARONE ◽  
Norma de Paula CAVALHEIRO ◽  
Fátima Mitiko TENGAN ◽  
Cristina GUASTINI

The objective of this study was to evaluate the prevalence of hepatitis B and C viruses in a group of HIV infected patients, followed at a single institution since 1996. 1,693 HIV positive patients (1,162 male, 531 female) were tested for HBV infection. Virological markers for HBV included HBsAg and total anti-HBc by ELISA. 1,457 patients (1,009 male, 448 female) were tested for HCV infection. Detection of HCV antibodies was carried out by ELISA. A sample of HCV antibody positive patients was tested for HCV by PCR to confirm infection. Of 1,693 patients tested for HBV, 654 (38.6%) and 96 (5.7%) were anti-HBc and HBsAg positive, respectively. Of 1,457 patients tested for HCV, 258 (17.7%) were anti-HCV positive. 82 of these patients were also tested by PCR and 81 were positive (98%). Of 1,411 patients tested for HBV and HCV 26 (1.8%) were positive for both viruses.


Author(s):  
Mariza Vono Tancredi ◽  
CSB Domingues ◽  
A Tayra ◽  
MA Silva ◽  
MC Gianna
Keyword(s):  

BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e040092
Author(s):  
Robert J Wozniak ◽  
Natalia B Cerqueira ◽  
Maria Candida S Dantas ◽  
Bianca Mahafe ◽  
Daniel A C Barros ◽  
...  

ObjectiveCharacterising the perceptions of groups most affected by HIV is fundamental in establishing guidelines for biomedical advancement. Although Brazil has successfully fought HIV/AIDS through several measures, transgender women still have a likelihood of HIV infection 55 times higher than the general population. This study aimed to better understand the perception and awareness of HIV cure research among the trans-identifying population in São Paulo, Brazil, and to determine factors that motivate or discourage participation in HIV cure studies.SettingThis cross-sectional study analysed data collected from a questionnaire administered to 118 transgender women and travestis at 5 sites within the city of São Paulo. It uses quantitative methodology to describe the perspectives of transgender and travesti people in relation to HIV cure research and the context in which such perspectives are produced.ResultsOf 118 participants, most participants (73%) had some knowledge of HIV cure research and were most willing to participate in online surveys (52%), interviews (52%), focus groups (52%) and studies involving blood draws (57%). Those with a higher education or employment status were more likely to agree that someone had been cured of HIV, people living with HIV are discriminated against, and more information about HIV cure research is needed before the community embraces it. Only 55% of participants completely trusted their physician. The biggest motivational factors included gaining additional knowledge about HIV infection (77%) and the potential for a longer, healthier life for all (73%).ConclusionsAs a primary analysis of HIV cure attitudes among the transgender and travesti population as well as the social context in which they are formed, this study identifies opportunities to strengthen the dialogue and develop more educational collaborations between scientific investigators, community educators and the trans-identifying population to ensure that HIV cure research is inclusive of diverse perspectives.


2017 ◽  
Vol 50 (1) ◽  
pp. 110-112 ◽  
Author(s):  
Elaine Monteiro Matsuda ◽  
Daniela Rodrigues Colpas ◽  
Norberto Camilo Campos ◽  
Luana Portes Ozorio Coelho ◽  
Andreia Moreira dos Santos Carmo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document